跳至主要内容
临床试验/ISRCTN16429332
ISRCTN16429332进行中(未招募)未知

A parallel-design randomized controlled trial investigating the treatment of metabolic acidosis in patients with chronic kidney disease with either sodium citrate versus sodium bicarbonate

Institutul Clinic Fundeni0 个研究点目标入组 50 人开始时间: 2021年9月22日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age >18 years
  • 2. eGFR 15-45 ml/min/1.73 m² CKD EPI
  • 3. Serum bicarbonate 10-22 mmol/l on to two different ocassions
  • 4. Ability to travel to study visits
  • 5. Ability to follow the study treatment regimen
  • 6. A wash-out period of one month if previous alkali therapy (such as sodium bicarbonate, sodium citrate, potassium citrate, baking soda, etc)

排除标准

  • 1. Hipokalemia <3 meq/l
  • 2. Uncontrolled blood pressure (>150/90 mmhg under treatment with more than 3 different classes of antihypertensive drugs, including diuretics)
  • 3. Heart failure with active class III or IV New York Heart Association, known left ventricular ejection fraction =30%, or hospital admission for heart failure within the past 3 months
  • 4. Hypervolemia of any cause (nephrotic syndrome, liver, or heart failure) considered unsafe for the patient by the PI for the patient
  • 5. Active hepatic disease
  • 6. Chronic gastrointestinal disorder (treatment adherence unreliable)
  • 7. Active malignancy
  • 8. Pregnancy
  • 9. Patients taking amilorid or sevelamer
  • 10. Patients refusing to sign the informed consent

研究者

相似试验